Likewise, a morpholino was used to correct aberrant splicing in a mouse bearing a PLP1 exon 3 variant that in humans causes PMD, spastic paraplegia 2, and hypomyelination of early myelinating structures90. The gene discussed is PLP1; the disease is Spastic paraplegia type 2.